Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Carparts.Com Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Carparts.Com Inc trades at $5.87 (market cap $47.94M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Carparts.Com Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | PRTS | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $11.40 |
52-Week Low | $23.09 | $3.88 |
Market Cap | — | $47.94M |
Enterprise Value | — | $62.92M |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PRTS trades at $5.87, down 1.92% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of $50.44 million in 2025, though recent quarters have beaten EPS estimates. A recent reverse stock split and new credit facility aim to stabilize operations amid declining revenue trends from $676 million in 2023 to $548 million in 2025.
The outlook remains challenging with persistent losses and negative cash flow, but analyst consensus is positive with 60% buy ratings. Key risks include sustained unprofitability and competitive pressures, while potential upside hinges on cost control and execution of strategic initiatives to return to growth.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →